蓝帆医疗股份有限公司第六届董事会第三十七次会议决议公告

Group 1 - The company held its 37th meeting of the sixth board of directors on January 7, 2026, via electronic communication, with all 8 directors participating [2][3]. - The board proposed to lower the conversion price of the "Blue Sail Convertible Bond" due to the stock price being below 85% of the current conversion price for at least 15 out of the last 30 trading days [3][12][28]. - The proposed adjustment to the conversion price requires approval from the shareholders' meeting, and the new price must not be lower than the higher of the average stock price over the last 20 trading days before the meeting or the latest audited net asset value per share [3][28]. Group 2 - The company plans to hold its first extraordinary shareholders' meeting of 2026 on January 26, 2026, to discuss the proposed adjustment to the bond conversion price [6][7][32]. - The meeting will be conducted both in-person and via online voting, with specific time slots for voting outlined [34][45]. - Shareholders holding the convertible bonds must abstain from voting on the proposal to adjust the conversion price [40].